Status:
UNKNOWN
Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia
Lead Sponsor:
Asia University
Conditions:
Sarcopenia
Eligibility:
All Genders
65-95 years
Phase:
NA
Brief Summary
Background: Declines in muscle mass and strength are expected with aging, but physical inactivity and low protein intake have been suggested as risk factors of sarcopenia. So far, lifestyle interventi...
Detailed Description
Background: Sarcopenia is defined as an abnormal loss of muscle mass and strength. Declines in muscle mass and strength are expected with aging, but physical inactivity and low protein intake have bee...
Eligibility Criteria
Inclusion
- 65-95 years old
- can communicate in Mandarin or Taiwanese language
- sacorpenia (basing on criteria of Asian Working Group for Sarcopenia )
Exclusion
- with liver or kidney disease
- stent in body.
Key Trial Info
Start Date :
August 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04516421
Start Date
August 24 2020
End Date
June 30 2022
Last Update
February 14 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Keelung Hospital Daycare Center, Ministry of Health and Welfare
Keelung, Taiwan, 201
2
Keelung First Daycare Center
Keelung, Taiwan, 202
3
Keelung Second Daycare Center
Keelung, Taiwan, 206